AAPL vs TOVX · P/E 39, rev $416.16B vs rev $300.0K
Apple Inc (AAPL) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
AAPL currently screens at market cap $3.83T and trailing P/E 39.2. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the AAPL and TOVX stock pages for the full models.
Not investment advice.